Oxford Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,539	Closed	-$595K	–	463
2025 Q4	$595K	Buy	+7,539	New	+$653K	0.22%	155
2019 Q4	–	Sell	-23,285	Closed	-$1.7M	–	1736
2019 Q3	$1.7M	Sell	23,285 -31,507	-58%	-$2.36M	0.04%	640
2019 Q2	$4.5M	Buy	54,792 +44,571	+436%	+$3.17M	0.1%	273
2019 Q1	$721K	Buy	10,221 +703	+7%	+$41.4K	0.02%	1078
2018 Q4	$429K	Buy	9,518 +3,068	+48%	+$161K	0.01%	1253
2018 Q3	$361K	Sell	6,450 -31,783	-83%	-$1.94M	0.01%	1436
2018 Q2	$2.57M	Sell	38,233 -13,803	-27%	-$862K	0.05%	511
2018 Q1	$3.03M	Buy	52,036 +3,708	+8%	+$235K	0.06%	359
2017 Q4	$3.18M	Buy	+48,328	New	+$3.01M	0.07%	355
2016 Q4	–	Sell	-21,986	Closed	-$1.46M	–	762
2016 Q3	$1.46M	Sell	21,986 -57,903	-72%	-$3.62M	0.05%	453
2016 Q2	$4.46M	Buy	79,889 +13,810	+21%	+$671K	0.15%	168
2016 Q1	$2.22M	Sell	66,079 -93,228	-59%	-$3.16M	0.06%	352
2015 Q4	$7.18M	Buy	+159,307	New	+$6.86M	0.17%	123